Literature DB >> 24233615

Study of plasma membrane heterogeneity using a phosphatidylcholine derivative of 1,6-diphenyl-1,3,5-hexatriene [2-(3-(diphenylhexatriene)propanoyl)-3-palmitoyl-L-α-phosphatidylcholine].

A Tangorra1, G Ferretti, G Zolese, G Curatola.   

Abstract

The fluorescent probe 1,6-diphenyl-1,3,5-hexatriene (DPH) and DPH derivatives have been used to characterize structural and physicochemical properties of specific membrane domains. Steady-state and fluorescence decay measurements of three probes, DPH (1,6-diphenyl-1,3,5-hexatriene), TMA-DPH [1-(4-trimethyl-ammonium-phenyl)-6-phenyl-1,3,5-hexatriene], and a phosphatidylcholine derivative of DPH, DPH-pPC [2-(3-(diphenylhexatriene)propanoyl)-3-pamitoyl-L-α-phosphatidyl choline], have been performed in erythrocyte membranes and in lymphocyte plasma membranes. The steady-state fluorescence polarization of the three probes showed a similar trend in both membranes. In fact either in erythrocyte or in lymphocyte plasma membranes the fluorescence polarization values of DPH-pPC and TMA-DPH were similar, but significantly higher with respect to DPH. A better characterization of erythrocyte and lymphocyte plasma membranes was possible by using fluorescence decay measurements. The data suggest the possible use of different DPH derivatives to characterize specific domains in biological membranes.

Entities:  

Year:  1994        PMID: 24233615     DOI: 10.1007/BF01881456

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  18 in total

1.  Interaction of a phosphatidylcholine derivative of 1,6-diphenyl-1,3,5-hexatriene (DPH-PC) with lymphocytes.

Authors:  G Ferretti; A Tangorra; G Curatola
Journal:  Biochem Int       Date:  1992-02

2.  Resolution of phospholipid conformational heterogeneity in model membranes by spin-label EPR and frequency-domain fluorescence spectroscopy.

Authors:  T C Squier; J E Mahaney; J J Yin; C S Lai; J R Lakowicz
Journal:  Biophys J       Date:  1991-03       Impact factor: 4.033

3.  Resolvability of fluorescence lifetime distributions using phase fluorometry.

Authors:  J R Alcala; E Gratton; F G Prendergast
Journal:  Biophys J       Date:  1987-04       Impact factor: 4.033

Review 4.  Fluidity parameters of lipid regions determined by fluorescence polarization.

Authors:  M Shinitzky; Y Barenholz
Journal:  Biochim Biophys Acta       Date:  1978-12-15

5.  Properties of a phosphatidylcholine derivative of diphenyl hexatriene (DPH-PC) in lymphocyte membranes. A comparison with DPH and the cationic derivative TMA-DPH using static and dynamic fluorescence.

Authors:  G Ferretti; A Tangorra; G Zolese; G Curatola
Journal:  Membr Biochem       Date:  1993 Jan-Mar

6.  Fluorescence lifetime distributions of 1,6-diphenyl-1,3,5-hexatriene reveal the effect of cholesterol on the microheterogeneity of erythrocyte membrane.

Authors:  R M Fiorini; M Valentino; M Glaser; E Gratton; G Curatola
Journal:  Biochim Biophys Acta       Date:  1988-04-22

7.  The dynamics of lipid motion in sarcoplasmic reticulum membranes determined by steady-state and time-resolved fluorescence measurements on 1,6-diphenyl-1,3,5-hexatriene and related molecules.

Authors:  C D Stubbs; K Kinosita; F Munkonge; P J Quinn; A Ikegami
Journal:  Biochim Biophys Acta       Date:  1984-09-05

8.  Plasma membrane fluidity measurements on whole living cells by fluorescence anisotropy of trimethylammoniumdiphenylhexatriene.

Authors:  J G Kuhry; G Duportail; C Bronner; G Laustriat
Journal:  Biochim Biophys Acta       Date:  1985-04-22

9.  Differential study of phosphatidylcholine and sphingomyelin in human high-density lipoproteins with lipid-specific fluorescent probes.

Authors:  J G Molotkovsky; Y M Manevich; E N Gerasimova; I M Molotkovskaya; V A Polessky; L D Bergelson
Journal:  Eur J Biochem       Date:  1982-03-01

10.  Fluorescence dynamics of diphenyl-1,3,5-hexatriene-labeled phospholipids in bilayer membranes.

Authors:  E H Pap; J J ter Horst; A van Hoek; A J Visser
Journal:  Biophys Chem       Date:  1994-01       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.